The role of YB-1 phosphorylation in mediating drug resistance has been reported in sorafenib-resistant hepatocellular carcinoma cells and diffuse large B-cell lymphoma [30, 32, 33]. This evidence concerns the gene YBX1 and hepatocellular carcinoma.